Last year, Connecticut became a "safe harbor" state for abortion access. In this session of the General Assembly, the focus is on access to contraception by allowing pharmacists to prescribe birth control.
NCPA submitted comments to FDA’s proposed rule, Nonprescription Drug Product With an Additional Condition for Nonprescription Use. According to the proposed rule, under an ACNU, a drug manufacturer must ensure that patients can appropriately self-select a medication.
The Food and Drug Administration has indefinitely postponed a meeting scheduled for this Friday to review an application for the first over-the-counter birth control pill as more Americans may have to rely on contraception after the U.S. Supreme Court reversed Roe v. Wade this summer.
The Food and Drug Administration has indefinitely postponed a meeting scheduled for this Friday to review an application for the first over-the-counter birth control pill as more Americans may have to rely on contraception after the U.S. Supreme Court reversed Roe v. Wade this summer.